Ampio Pharma (AMPE) Provides Results from Ampion Trials; Primary End Point Was Not Met
Tweet Send to a Friend
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) announced today the results of the Ampion™ PIVOT clinical trial as well as a comprehensive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
